Miscellaneous
The recent EASD annual meeting provided the opportunity for a lot of new data to be presented - however, what were the key highlights, and how might these impact practice? We joined three leading experts in diabetes to hear their thoughts on a number of topics, including: - Professor Chantal Mathieu, for a discussion of the DAPA-CKD and EMPEROR-Reduced trials - Dr Tim Heise, for a discussion of once-weekly basal insulin - Professor Carel le Roux, for a discussion of the STEP trials and MAFLD in diabetes This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.